| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| November 7th, 2005 | 15 | Yes |
Popular Name: Guanadrel sulfate Guanadrel sulfate
Find On: PubMed — Wikipedia — Google
CAS Numbers: 1443980-00-4 , 22195-34-2 , 40580-59-4
(1,4-Dioxaspiro(4.5)dec-2-ylmethyl)guanidine sulfate (2:1)
1-{1,4-dioxaspiro[4.5]decan-2-ylmethyl}guanidine hydroiodide
2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine
22195-34-2; D00607; Guanadrel sulfate (USP); Hylorel (TN)
40580-59-4; D08029; Guanadrel (INN); Hylorel (TN)
Guanadrel (INN); Guanadrel Sulfate (FDA
Guanidine (1,4-dioxaspiro(4.5)dec-2-ylmethyl)-, sulfate (2:1)
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 0.96 | 3.04 | -32.71 | 5 | 5 | 1 | 82 | 214.289 | 3 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
| Therapy | antihypertensive | SMDC Pharmakon |
| PUBCHEM_PATENT_ID | EP0351897A2; US4514407; US4689413; US5795909; US5891465; WO1997042938A1; WO1999008596A1; WO1999008597A1; WO1999030690A1; WO2000050020A2 | IBM Patent Data |
| Patent Database Links | WO2007098390 | ChEBI |
